General Information of the Compound
Compound ID |
CP0438096
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(4-{4-[2-Hydroxy-2-(4-hydroxy-3-methanesulfonylamino-phenyl)-ethylamino]-piperidin-1-yl}-benzoylamino)-acetic acid ethyl ester
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C25H34N4O7S
|
||||||||||||||||||
Molecular Weight |
534.635
|
||||||||||||||||||
Canonical SMILES |
CCOC(=O)CNC(=O)c1ccc(cc1)N1CCC(CC1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C25H34N4O7S/c1-3-36-24(32)16-27-25(33)17-4-7-20(8-5-17)29-12-10-19(11-13-29)26-15-23(31)18-6-9-22(30)21(14-18)28-37(2,34)35/h4-9,14,19,23,26,28,30-31H,3,10-13,15-16H2,1-2H3,(H,27,33)/t23-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
SZTDHZDMVLKTOM-QHCPKHFHSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT01493, Beta-3 adrenergic receptor